
Glykad PG 2mg/500mg/15mg Tablet SR
Marketer
Salveo Lifecare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glykad PG 2mg/500mg/15mg Tablet SR
Combiflex-D 2mg/500mg/15mg Extended-Release Tablets offer a multi-component approach to managing blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin utilization, consequently reducing elevated blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex-D 2mg/500mg/15mg Extended-Release Tablets. Ingestion with food is recommended to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Excessive medication can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol consumption, or meal skipping elevates the risk of hypoglycemia in some individuals; diligent blood glucose monitoring is crucial. Common adverse reactions may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating women must consult their physician before initiating therapy. Kidney function assessment is standard practice before prescription. Limit alcohol consumption during treatment to mitigate the potential for increased side effects.
Uses of Glykad PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glykad PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glykad PG 2mg/500mg/15mg Tablet SR whole; do not chew, crush, or divide it. Administer this medication with a meal.
Common Side effects of Glykad PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glykad PG 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Glykad PG 2mg/500mg/15mg Extended-Release Tablets should be taken with a meal.
How Glykad PG 2mg/500mg/15mg Tablet SR works:
Glykad PG SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with complementary actions. This triple therapy effectively manages blood glucose levels when monotherapy or dual combinations prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glykad PG 2mg/500mg/15mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glykad PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glykad PG 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glykad PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Glykad PG 2mg/500mg/15mg SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glykad PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glykad PG 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glykad PG 2mg/500mg/15mg Tablet SR :
Should you forget to take your Glykad PG 2mg/500mg/15mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glykad PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
